The future of the Chemiluminescence Immunoassay (CLIA) Market looks promising as healthcare providers increasingly rely on high-throughput and precise diagnostic solutions. Recent technological advancements, such as multiplex CLIA systems, are enabling simultaneous detection of multiple biomarkers, thereby improving diagnostic efficiency. The demand for personalized medicine is also...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt